| PTO Form 1581 (Rev 4/2000) |
| OMB Control #0651-0009 (Exp. 06/30/2005) |
Extension Statement of Use Filing
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
76388645 |
| LAW OFFICE ASSIGNED |
LAW OFFICE 105 |
| MARK SECTION |
| MARK |
ELIQUIS |
| OWNER SECTION (current) |
| NAME |
Pfizer Inc. |
| STREET |
235 East 42nd Street |
| CITY |
New York |
| STATE |
NY |
| ZIP/POSTAL CODE |
10017 |
| COUNTRY |
US |
| OWNER SECTION (proposed) |
| NAME |
Pfizer Inc. |
| STREET |
235 East 42nd Street |
| CITY |
New York |
| STATE |
NY |
| ZIP/POSTAL CODE |
10017 |
| COUNTRY |
US |
| PHONE |
(212) 733-2323 |
| FAX |
(212) 573-2273 |
| ATTORNEY SECTION |
| NAME |
Stacey Hallerman |
| FIRM NAME |
Pfizer Inc. / Legal Division |
| STREET |
150 East 42nd Street |
| CITY |
New York |
| STATE |
NY |
| ZIP/POSTAL CODE |
10017 |
| COUNTRY |
USA |
| PHONE |
(212) 744-4114 |
| FAX |
(212) 573-2273 |
| DOCKET NUMBER |
PHR/USA/ELIQUIS |
| OTHER APPOINTED ATTORNEY |
Cynthia Arellano, Christopher Bolinger, Richard A. Friedman, Heather A. McDonald, Sudipta Rao, Arthur A. Silverstein, Tiffany Trunko, Jane S. Ungaro, Jennet S. Walker, Cindy M.
Zelson, Warren L. Zeserman |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| KEEP EXISTING GOODS AND/OR SERVICES |
YES |
| EXTENSION SECTION |
| EXTENSION NUMBER |
3 |
| ONGOING EFFORT |
The product on which Applicant intends to use this mark cannot be marketed at present because ongoing clinical development and market research is continuing.' |
| ALLOWANCE MAIL DATE |
12/31/2002 |
| STATEMENT OF USE |
NO |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| SUBTOTAL AMOUNT |
150 |
| TOTAL AMOUNT |
150 |
| SIGNATURE SECTION |
| SIGNATURE |
/stacey hallerman/ |
| SIGNATORY NAME |
Stacey Hallerman |
| SIGNATORY DATE |
06/17/2004 |
| SIGNATORY POSITION |
Senior Trademark Counsel |
| FILING INFORMATION |
| SUBMIT DATE |
Thu Jun 17 14:59:06 EDT 2004 |
| TEAS STAMP |
USPTO/ESU-XXX.XX.XXX.X-20
040617145906395149-763886
45-20074f23f4f87ebbb8baa4
ff794d9705276-DA-45-20040
617142814309212 |
| PTO Form 1581 (Rev 4/2000) |
| OMB Control #0651-0009 (Exp. 06/30/2005) |
Trademark/Service Mark Extension for Filing a Statement of Use
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ELIQUIS
SERIAL NUMBER: 76388645
The applicant, Pfizer Inc., residing at 235 East 42nd Street , New York, NY US 10017, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this
application. The Notice of Allowance mailing date was 12/31/2002.
For International Class: 005, the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of
the goods and/or services listed in the Notice of Allowance, or as subsequently modified.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: The product on which Applicant intends to use this mark cannot be marketed at present because ongoing clinical development and market research is continuing.' .
The applicant hereby appoints Stacey Hallerman and Cynthia Arellano, Christopher Bolinger, Richard A. Friedman, Heather A. McDonald, Sudipta Rao, Arthur A. Silverstein, Tiffany Trunko, Jane S.
Ungaro, Jennet S. Walker, Cindy M. Zelson, Warren L. Zeserman of Pfizer Inc. / Legal Division, 150 East 42nd Street, New York, NY USA 10017 to submit this Request for Extension of Time to File
a Statement of Use on behalf of the applicant. The attorney docket/reference number is PHR/USA/ELIQUIS.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /stacey hallerman/ Date: 06/17/2004
Signatory's Name: Stacey Hallerman
Signatory's Position: Senior Trademark Counsel
Mailing Address:
Pfizer Inc. / Legal Division
150 East 42nd Street
New York, NY 10017
RAM Sale Number: 45
RAM Accounting Date: 06/18/2004
Serial Number: 76388645
Internet Transmission Date: Thu Jun 17 14:59:06 EDT 2004
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.X-20040617145906395
149-76388645-20074f23f4f87ebbb8baa4ff794
d9705276-DA-45-20040617142814309212
Go Back